Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

6-month Evaluation of the Efficacy and Safety of Synolis VA 80/160 in the Treatment of Symptomatic Hip Osteoarthritis

NCT05829733 is registered in ClinicalTrials.gov with Aptissen SA as lead sponsor.

NCT NCT05829733
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05829733 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
6-month Evaluation of the Efficacy and Safety of Synolis VA 80/160 in the Treatment of Symptomatic Hip Osteoarthritis
Lead sponsor
Aptissen SA
Phase
Not applicable
Overall status
Recruiting
Start date
May 27, 2024
Completion date
April 30, 2027
Enrollment
70 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

osteoarthritis, hip